Beverloo HB - Search Results

1

NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Pratcorona M, Abbas S, Kuipers JE, van Galen JF, Beverloo HB, Sonneveld E, Kaspers GJ, Trka J, Baruchel A, Zimmermann M, Creutzig U, Reinhardt D, Pieters R, Valk PJ, Zwaan CM. Hollink IH, et al. Among authors: beverloo hb. Blood. 2011 Sep 29;118(13):3645-56. doi: 10.1182/blood-2011-04-346643. Epub 2011 Aug 2. Blood. 2011. PMID: 21813447 Free article.

2

The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene.

Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R, Young BD. Chaplin T, et al. Among authors: beverloo hb. Blood. 1995 Sep 15;86(6):2073-6. Blood. 1995. PMID: 7662954 Free article.

3

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

Ramakers-van Woerden NL, Pieters R, Loonen AH, Hubeek I, van Drunen E, Beverloo HB, Slater RM, Harbott J, Seyfarth J, van Wering ER, Hählen K, Schmiegelow K, Janka-Schaub GE, Veerman AJ. Ramakers-van Woerden NL, et al. Among authors: beverloo hb. Blood. 2000 Aug 1;96(3):1094-9. Blood. 2000. PMID: 10910927 Free article.

4

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.

Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R, Slater R, Smit EM, Beverloo HB, Verhoef G, Verdonck LF, Ossenkoppele GJ, Sonneveld P, de Greef GE, Löwenberg B, Delwel R. Barjesteh van Waalwijk van Doorn-Khosrovani S, et al. Among authors: beverloo hb. Blood. 2003 Feb 1;101(3):837-45. doi: 10.1182/blood-2002-05-1459. Epub 2002 Oct 3. Blood. 2003. PMID: 12393383 Free article.

5

Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.

Stams WA, den Boer ML, Beverloo HB, Meijerink JP, Stigter RL, van Wering ER, Janka-Schaub GE, Slater R, Pieters R. Stams WA, et al. Among authors: beverloo hb. Blood. 2003 Apr 1;101(7):2743-7. doi: 10.1182/blood-2002-08-2446. Epub 2002 Nov 14. Blood. 2003. PMID: 12433682 Free article.

6

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.

Ramakers-van Woerden NL, Beverloo HB, Veerman AJ, Camitta BM, Loonen AH, van Wering ER, Slater RM, Harbott J, den Boer ML, Ludwig WD, Haas OA, Janka-Schaub GE, Pieters R. Ramakers-van Woerden NL, et al. Among authors: beverloo hb. Leukemia. 2004 Mar;18(3):521-9. doi: 10.1038/sj.leu.2403253. Leukemia. 2004. PMID: 14712291

7

Prognostically useful gene-expression profiles in acute myeloid leukemia.

Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Löwenberg B, Delwel R. Valk PJ, et al. Among authors: beverloo hb. N Engl J Med. 2004 Apr 15;350(16):1617-28. doi: 10.1056/NEJMoa040465. N Engl J Med. 2004. PMID: 15084694 Free article.

8

Novel murine B-cell lymphoma/leukemia model to study BCL2-driven oncogenesis.

Meijerink JP, Van Lieshout EM, Beverloo HB, Van Drunen E, Mensink EJ, Macville M, Pieters R. Meijerink JP, et al. Among authors: beverloo hb. Int J Cancer. 2005 May 10;114(6):917-25. doi: 10.1002/ijc.20822. Int J Cancer. 2005. PMID: 15645425 Free article.

9

Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

Stams WA, den Boer ML, Holleman A, Appel IM, Beverloo HB, van Wering ER, Janka-Schaub GE, Evans WE, Pieters R. Stams WA, et al. Among authors: beverloo hb. Blood. 2005 Jun 1;105(11):4223-5. doi: 10.1182/blood-2004-10-3892. Epub 2005 Feb 17. Blood. 2005. PMID: 15718422 Free article.

10

Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.

Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R. Stams WA, et al. Among authors: beverloo hb. Clin Cancer Res. 2005 Apr 15;11(8):2974-80. doi: 10.1158/1078-0432.CCR-04-1829. Clin Cancer Res. 2005. PMID: 15837750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page